Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
SKYE is expected to report earnings to fall 22.78% to -24 cents per share on August 07
Q2'26
Est.
$-0.25
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.10
Q3'25
Missed
by $0.09
Q2'25
Missed
by $0.22
The last earnings report on May 11 showed earnings per share of -31 cents, missing the estimate of -28 cents. With 84.55K shares outstanding, the current market capitalization sits at 23.68M.